FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283263885> ?p ?o ?g. }

• W4283263885 endingPage "e511" @default.
• W4283263885 startingPage "e507" @default.
• W4283263885 abstract "Neurogenic detrusor overactivity (NDO) is treated with antimuscarinics as first-line treatment. For patients with contraindications or unresponsive, intradetrusor injections with botulinum toxin (BoNT) are a safe and effective but expensive option.Our study evaluated whether adding solifenacin to the intradetrusor injection of BoNT A could boost the effect of BoNT in patients with NDO due to multiple sclerosis or spinal cord injury refractory to antimuscarinics alone and/or lead to less frequent injections.We performed a prospective study on 49 patients assigned alternatively to group A, undergoing BoNT injections, and group B, adding solifenacin.We gathered data from urodynamic testing and questionnaire assessments before and 3 months after injections and reinjections. We analyzed 39 patients who achieved total continence and a minimum 24-month follow-up period.After treatment, both groups had statistically significant improvement of overactive bladder questionnaire (OABq) score, post void residue (PVR), and peak detrusor pressure (Pdet). Reinjection was needed after a mean 8.2 months for group A and 11.7 months for group B. We analyzed the improvement rate of parameters compared between the 2 groups-group B had greater OABq score improvement (A = 17.25 ± 5.07, B = 20.44 ± 4.51, P = 0.0485), as well as for maximum bladder capacity (A = 11.05 ± 7.04 mL, B = 19.39 ± 6.43 mL, P = 0.0005); differences in Pdet change (A = 51.72 ± 16.57 cmH 2 O, B = 50.80 ± 16.33 cmH 2 O, P = 0.7635) and PVR change (A = 17.67 ± 12.63 mL, B = 12.30 ± 8.32 mL, P = 0.126) were not statistically significant.Our study shows that adding solifenacin improves patient satisfaction, increases the interval between reinjections, thus lowering costs, and improves maximum bladder capacity. Pdet was kept in safe ranges, but no statistically significant conclusions could be drawn regarding Pdet and PVR decrease related to adding solifenacin. Although our study is limited by the small series of patients and lack of randomization and placebo control group, the BoNT-solifenacin combination could be considered in NDO in terms of cost-effectiveness. Further studies would be beneficial." @default.
• W4283263885 created "2022-06-23" @default.
• W4283263885 creator A5046974921 @default.
• W4283263885 creator A5052793111 @default.
• W4283263885 creator A5077323853 @default.
• W4283263885 creator A5085353911 @default.
• W4283263885 date "2022-06-21" @default.
• W4283263885 modified "2023-10-18" @default.
• W4283263885 title "Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity" @default.
• W4283263885 cites W1486407121 @default.
• W4283263885 cites W1973736267 @default.
• W4283263885 cites W2046640285 @default.
• W4283263885 cites W2081071477 @default.
• W4283263885 cites W2122121014 @default.
• W4283263885 cites W2140757158 @default.
• W4283263885 cites W2341515385 @default.
• W4283263885 cites W2888683170 @default.
• W4283263885 cites W2893664763 @default.
• W4283263885 cites W3082702356 @default.
• W4283263885 doi "https://doi.org/10.1097/mjt.0000000000001531" @default.
• W4283263885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35731251" @default.
• W4283263885 hasPublicationYear "2022" @default.
• W4283263885 type Work @default.
• W4283263885 citedByCount "6" @default.
• W4283263885 countsByYear W42832638852022 @default.
• W4283263885 countsByYear W42832638852023 @default.
• W4283263885 crossrefType "journal-article" @default.
• W4283263885 hasAuthorship W4283263885A5046974921 @default.
• W4283263885 hasAuthorship W4283263885A5052793111 @default.
• W4283263885 hasAuthorship W4283263885A5077323853 @default.
• W4283263885 hasAuthorship W4283263885A5085353911 @default.
• W4283263885 hasConcept C118552586 @default.
• W4283263885 hasConcept C121332964 @default.
• W4283263885 hasConcept C126322002 @default.
• W4283263885 hasConcept C126894567 @default.
• W4283263885 hasConcept C142424586 @default.
• W4283263885 hasConcept C142724271 @default.
• W4283263885 hasConcept C204787440 @default.
• W4283263885 hasConcept C2777478456 @default.
• W4283263885 hasConcept C2777785397 @default.
• W4283263885 hasConcept C2778334475 @default.
• W4283263885 hasConcept C2778531004 @default.
• W4283263885 hasConcept C2778941218 @default.
• W4283263885 hasConcept C2779502394 @default.
• W4283263885 hasConcept C2779762690 @default.
• W4283263885 hasConcept C2780616540 @default.
• W4283263885 hasConcept C2780775167 @default.
• W4283263885 hasConcept C2781036200 @default.
• W4283263885 hasConcept C42219234 @default.
• W4283263885 hasConcept C71924100 @default.
• W4283263885 hasConcept C87355193 @default.
• W4283263885 hasConceptScore W4283263885C118552586 @default.
• W4283263885 hasConceptScore W4283263885C121332964 @default.
• W4283263885 hasConceptScore W4283263885C126322002 @default.
• W4283263885 hasConceptScore W4283263885C126894567 @default.
• W4283263885 hasConceptScore W4283263885C142424586 @default.
• W4283263885 hasConceptScore W4283263885C142724271 @default.
• W4283263885 hasConceptScore W4283263885C204787440 @default.
• W4283263885 hasConceptScore W4283263885C2777478456 @default.
• W4283263885 hasConceptScore W4283263885C2777785397 @default.
• W4283263885 hasConceptScore W4283263885C2778334475 @default.
• W4283263885 hasConceptScore W4283263885C2778531004 @default.
• W4283263885 hasConceptScore W4283263885C2778941218 @default.
• W4283263885 hasConceptScore W4283263885C2779502394 @default.
• W4283263885 hasConceptScore W4283263885C2779762690 @default.
• W4283263885 hasConceptScore W4283263885C2780616540 @default.
• W4283263885 hasConceptScore W4283263885C2780775167 @default.
• W4283263885 hasConceptScore W4283263885C2781036200 @default.
• W4283263885 hasConceptScore W4283263885C42219234 @default.
• W4283263885 hasConceptScore W4283263885C71924100 @default.
• W4283263885 hasConceptScore W4283263885C87355193 @default.
• W4283263885 hasIssue "5" @default.
• W4283263885 hasLocation W42832638851 @default.
• W4283263885 hasLocation W42832638852 @default.
• W4283263885 hasOpenAccess W4283263885 @default.
• W4283263885 hasPrimaryLocation W42832638851 @default.
• W4283263885 hasRelatedWork W1964894466 @default.
• W4283263885 hasRelatedWork W1969146667 @default.
• W4283263885 hasRelatedWork W1980265965 @default.
• W4283263885 hasRelatedWork W1986851952 @default.
• W4283263885 hasRelatedWork W1999733635 @default.
• W4283263885 hasRelatedWork W2335438033 @default.
• W4283263885 hasRelatedWork W2359564606 @default.
• W4283263885 hasRelatedWork W4242074381 @default.
• W4283263885 hasRelatedWork W4256631357 @default.
• W4283263885 hasRelatedWork W69721835 @default.
• W4283263885 hasVolume "29" @default.
• W4283263885 isParatext "false" @default.
• W4283263885 isRetracted "false" @default.
• W4283263885 workType "article" @default.